ZIMMER BIOMET HOLDINGS, INC. Investment Income, Interest
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Investment Income, Interest of $800.00 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-01.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2018-11-01
- ZIMMER BIOMET HOLDINGS, INC. investment income, interest for the quarter ending 2018-09-30 was $800.00K, a 33.33% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. investment income, interest for the quarter ending 2018-06-30 was $600.00K, a 100.00% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. investment income, interest for the quarter ending 2018-03-31 was $900.00K, a 80.00% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. investment income, interest for the quarter ending 2017-12-31 was $800.00K, a 300.00% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. investment income, interest for fiscal 2017 was $2.20M, a 24.14% decline from fiscal 2016.
- ZIMMER BIOMET HOLDINGS, INC. investment income, interest for fiscal 2016 was $2.90M, a 69.15% decline from fiscal 2015.
- ZIMMER BIOMET HOLDINGS, INC. investment income, interest for fiscal 2015 was $9.40M, a 21.01% decline from fiscal 2014.
- ZIMMER BIOMET HOLDINGS, INC. investment income, interest for fiscal 2014 was $11.90M, a 23.72% decline from fiscal 2013.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2018-09-30 | $800.00K 10-Q · filed 2018-11-01 | $1.40M derived: sum of 2 quarters · filed 2018-11-01 | $2.30M 10-Q · filed 2018-11-01 | $3.10M derived: sum of 4 quarters · filed 2018-11-01 |
| 2018-06-30 | $600.00K 10-Q · filed 2018-08-06 | $1.50M 10-Q · filed 2018-08-06 | $2.30M derived: sum of 3 quarters · filed 2018-08-06 | $2.90M derived: sum of 4 quarters · filed 2018-11-01 |
| 2018-03-31 | $900.00K 10-Q · filed 2018-05-08 | $1.70M derived: sum of 2 quarters · filed 2018-05-08 | $2.30M derived: sum of 3 quarters · filed 2018-11-01 | $2.60M derived: sum of 4 quarters · filed 2018-11-01 |
| 2017-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $1.40M derived: sum of 2 quarters · filed 2018-11-01 | $1.70M derived: sum of 3 quarters · filed 2018-11-01 | $2.20M 10-K · filed 2018-02-27 |
| 2017-09-30 | $600.00K 10-Q · filed 2018-11-01 | $900.00K derived: sum of 2 quarters · filed 2018-11-01 | $1.40M 10-Q · filed 2018-11-01 | $1.60M derived: sum of 4 quarters · filed 2018-11-01 |
| 2017-06-30 | $300.00K 10-Q · filed 2018-08-06 | $800.00K 10-Q · filed 2018-08-06 | $1.00M derived: sum of 3 quarters · filed 2018-08-06 | $1.60M derived: sum of 4 quarters · filed 2018-08-06 |
| 2017-03-31 | $500.00K 10-Q · filed 2018-05-08 | $700.00K derived: sum of 2 quarters · filed 2018-05-08 | $1.30M derived: sum of 3 quarters · filed 2018-05-08 | $2.10M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $800.00K derived: sum of 2 quarters · filed 2018-02-27 | $1.60M derived: sum of 3 quarters · filed 2018-02-27 | $2.90M 10-K · filed 2018-02-27 |
| 2016-09-30 | $600.00K 10-Q · filed 2017-11-06 | $1.40M derived: sum of 2 quarters · filed 2017-11-06 | $2.70M 10-Q · filed 2017-11-06 | $4.70M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $800.00K 10-Q · filed 2017-08-08 | $2.10M 10-Q · filed 2017-08-08 | $4.10M derived: sum of 3 quarters · filed 2018-02-27 | $6.40M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $1.30M 10-Q · filed 2017-05-09 | $3.30M derived: sum of 2 quarters · filed 2018-02-27 | $5.60M derived: sum of 3 quarters · filed 2018-02-27 | $8.10M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $4.30M derived: sum of 2 quarters · filed 2018-02-27 | $6.80M derived: sum of 3 quarters · filed 2018-02-27 | $9.40M 10-K · filed 2018-02-27 |
| 2015-09-30 | $2.30M 10-Q · filed 2015-11-09 | $4.80M derived: sum of 2 quarters · filed 2016-11-08 | $7.40M 10-Q · filed 2016-11-08 | $10.90M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $2.50M 10-Q · filed 2016-08-08 | $5.10M 10-Q · filed 2016-08-08 | $8.60M derived: sum of 3 quarters · filed 2017-03-01 | $11.60M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $2.60M 10-Q · filed 2016-05-10 | $6.10M derived: sum of 2 quarters · filed 2017-03-01 | $9.10M derived: sum of 3 quarters · filed 2017-03-01 | $12.00M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $6.50M derived: sum of 2 quarters · filed 2017-03-01 | $9.40M derived: sum of 3 quarters · filed 2017-03-01 | $11.90M 10-K · filed 2017-03-01 |
| 2014-09-30 | $3.00M 10-Q · filed 2015-11-09 | $5.90M derived: sum of 2 quarters · filed 2015-11-09 | $8.40M 10-Q · filed 2015-11-09 | $12.60M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $2.90M 10-Q · filed 2015-08-10 | $5.40M 10-Q · filed 2015-08-10 | $9.60M derived: sum of 3 quarters · filed 2016-02-29 | $13.40M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $2.50M 10-Q · filed 2015-05-07 | $6.70M derived: sum of 2 quarters · filed 2016-02-29 | $10.50M derived: sum of 3 quarters · filed 2016-02-29 | $14.40M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $8.00M derived: sum of 2 quarters · filed 2016-02-29 | $11.90M derived: sum of 3 quarters · filed 2016-02-29 | $15.60M 10-K · filed 2016-02-29 |
| 2013-09-30 | $3.80M 10-Q · filed 2014-11-05 | $7.70M derived: sum of 2 quarters · filed 2014-11-05 | $11.40M 10-Q · filed 2014-11-05 | $16.30M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-06-30 | $3.90M 10-Q · filed 2014-08-07 | $7.60M 10-Q · filed 2014-08-07 | $12.50M derived: sum of 3 quarters · filed 2015-02-23 | $16.30M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-03-31 | $3.70M 10-Q · filed 2014-05-06 | $8.60M derived: sum of 2 quarters · filed 2015-02-23 | $12.40M derived: sum of 3 quarters · filed 2015-02-23 | $16.20M derived: sum of 4 quarters · filed 2015-02-23 |
| 2012-12-31 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $8.70M derived: sum of 2 quarters · filed 2015-02-23 | $12.50M derived: sum of 3 quarters · filed 2015-02-23 | $15.60M 10-K · filed 2015-02-23 |
| 2012-09-30 | $3.80M 10-Q · filed 2013-11-12 | $7.60M derived: sum of 2 quarters · filed 2013-11-12 | $10.70M 10-Q · filed 2013-11-12 | $14.20M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-06-30 | $3.80M 10-Q · filed 2013-08-07 | $6.90M 10-Q · filed 2013-08-07 | $10.40M derived: sum of 3 quarters · filed 2014-02-28 | $11.70M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-03-31 | $3.10M 10-Q · filed 2013-05-08 | $6.60M derived: sum of 2 quarters · filed 2014-02-28 | $7.90M derived: sum of 3 quarters · filed 2014-02-28 | $11.20M derived: sum of 4 quarters · filed 2014-02-28 |
| 2011-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $4.80M derived: sum of 2 quarters · filed 2014-02-28 | $8.10M derived: sum of 3 quarters · filed 2014-02-28 | $10.10M 10-K · filed 2014-02-28 |
| 2011-09-30 | $1.30M 10-Q · filed 2012-11-06 | $4.60M derived: sum of 2 quarters · filed 2012-11-06 | $6.60M 10-Q · filed 2012-11-06 | |
| 2011-06-30 | $3.30M 10-Q · filed 2012-08-07 | $5.30M 10-Q · filed 2012-08-07 | ||
| 2011-03-31 | $2.00M 10-Q · filed 2012-05-03 | |||
| 2010-12-31 | $3.70M 10-K · filed 2013-02-27 | |||
| 2009-12-31 | $1.80M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |